Description

3-(2,4-Dimethyl-6-Oxo-2,6-Dihydro-7H-Pyrazolo[3,4-B]Pyridin-7-Yl)Propanoic Acid is a high-purity, advanced pharmaceutical intermediate with a complex heterocyclic structure. This compound is of significant value for its role as a critical building block in the synthesis of novel active pharmaceutical ingredients (APIs), particularly in therapeutic areas requiring targeted molecular scaffolds. It is primarily needed by research institutions and pharmaceutical manufacturers engaged in drug discovery and development programs. Our supply ensures consistent quality and reliable availability for your most demanding synthesis workflows.

Application

• Pharmaceutical Intermediate: Serves as a key precursor in the research and synthesis of new chemical entities (NCEs) and potential drug candidates.
• Medicinal Chemistry Research: Used as a core scaffold for constructing libraries of compounds in structure-activity relationship (SAR) studies.
• API Development: Integral in the development and scale-up processes for novel Active Pharmaceutical Ingredients, especially those targeting specific enzyme or receptor interactions.
• Biochemical Research: Employed in the study of biological pathways and as a tool compound in pharmacological assays.
• Contract Research & Manufacturing (CRO/CMO): Supplied to organizations providing custom synthesis and process development services.
• Academic Research: Utilized in university and institutional labs for advanced organic synthesis and heterocyclic chemistry projects.

Basic Information

Product Name	3-(2,4-Dimethyl-6-Oxo-2,6-Dihydro-7H-Pyrazolo[3,4-B]Pyridin-7-Yl)Propanoic Acid
CAS No.	1018165-46-2
Molecular Formula	C13H15N3O3
Molecular Weight	261.28 g/mol
Synonyms	3-(2,4-Dimethyl-6-oxo-2,6-dihydro-7H-pyrazolo[3,4-b]pyridin-7-yl)propanoic acid; 7H-Pyrazolo[3,4-b]pyridine-7-propanoic acid, 2,4-dimethyl-6-oxo-2,6-dihydro-; 1018165-46-2; 3-(2,4-Dimethyl-6-oxo-1,4,5,6-tetrahydropyrazolo[3,4-b]pyridin-7-yl)propanoic acid (tautomeric form); Pyrazolopyridine propanoic acid derivative
EINECS	Contact for details

Quality Control

Our 3-(2,4-Dimethyl-6-Oxo-2,6-Dihydro-7H-Pyrazolo[3,4-B]Pyridin-7-Yl)Propanoic Acid is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation, to ensure it meets the high standards required for pharmaceutical R&D. Certificates of Analysis (COA) detailing batch-specific results are available upon request, providing full traceability and compliance data for your quality assurance protocols.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed after opening to prevent degradation from atmospheric moisture. For long-term storage, consider using desiccants.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Loss on Drying	≤ 1.0%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 20 ppm
Single Unknown Impurity (HPLC)	≤ 0.5%
Total Impurities (HPLC)	≤ 2.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.